Results of experimental infection of vaccinated and non-vaccinated ducklings with duck hepatitis virus
https://doi.org/10.29326/2304-196X-2022-11-4-359-366
Abstract
Duck virus hepatitis, a highly contagious disease occurring in ducklings, is currently reported in all countries with duck breeding industry. This infection is included in the list of notifiable diseases of the World Organization for Animal Health, restrictive measures are established and the regionalization of the country’s territory is carried out in case of its occurrence. Timely vaccination of parent flocks in order to obtain immune offspring takes a priority place in the system of anti-epidemic measures. Due to active development of duck breeding industry and increasing number of backyard farms, the need for high-quality and effective prevention tools for this infectious disease is growing. To date, one domestic native vaccine produced by FGBI «ARRIAH» and registered in the Russian Federation is available in native form and is intended for parenteral use. In order to extend the vaccine’s shelf life and for storage and transportation convenience, a live freeze-dried vaccine against duck virus hepatitis is being developed. The paper presents results of studying the pathogenesis of duck virus hepatitis and evaluating the efficacy and safety of the vaccine under development. Pathomorphological studies carried out post experimental infection indicate that duck hepatitis virus induces pathogenic effect not only in birds’ digestive organs (the liver, in particular) but also causes degenerative changes in central and peripheral immune organs: in cloacal bursa, thymus and third eyelid gland, that may be manifested as deficiency of B- and T-cell immunity and requires further studies. It has been shown that in case of immunization of 3-day-old ducklings, the experimental vaccine induces antibody-mediated immune response, no harmful effect is produced on poultry if a tenfold dose is administered which indicates its safety, and the vaccine ensures protection against infection with a control virulent strain of hepatitis virus.
About the Authors
A. A. ChesnokovaRussian Federation
Alexandra A. Chesnokova, Post-Graduate Student, Leading Veterinarian, Laboratory for Epizootology and Monitoring
Vladimir
E. V. Ivanova
Russian Federation
Elizaveta V. Ivanova, Post-Graduate Student, Leading
Veterinarian, Laboratory for Avian Diseases Prevention
Vladimir
V. V. Pronin
Russian Federation
Valery V. Pronin, Doctor of Science (Biology), Professor, Head of the Centre for Preclinical Tests
Vladimir
O. A. Chupina
Russian Federation
Olga A. Chupina, Candidate of Science (Biology), Deputy Head of the Centre for Preclinical Tests
Vladimir
V. Yu. Fomenko
Russian Federation
Vadim Yu. Fomenko, Candidate of Science (Biology), Senior Researcher, Laboratory for Epizootology and Monitoring
Vladimir
M. S. Volkov
Russian Federation
Mikhail S. Volkov, Candidate of Sciences (Veterinary Medicine), Associate Professor, Head of Laboratory for Epizootology and Monitoring
Vladimir
V. N. Irza
Russian Federation
Viktor N. Irza, Doctor of Sciences (Veterinary Medicine), Associate Professor, Chief Researcher, Information and Analysis Centre
Vladimir
References
1. Viral hepatitis of ducks (ducks). In: Knyazev V. P. Diseases of Waterfowl. Vladimir; 2010; 70–87. (in Russ.)
2. Kontrimavichus L. M., Zolotarev M. G. Jepizooticheskie i kliniko-morfologicheskie dannye po virusnomu gepatitu utjat = Epizootic, clinical and morphological data on duck virus hepatitis. Veterinariya. 1965; 3: 44–46. (in Russ.)
3. Leonov I. K. Biological properties of duck virus hepatitis type I vaccine strains: author’s abstract of Candidate of Science thesis (Veterinary Medicine). Saint-Petersburg; 2018. 23 р. Available at: https://viewer.rsl.ru/ru/rsl01008705025?page=1&rotate=0&theme=white. (in Russ.)
4. Panikar I. I. Duck virus hepatitis and its prevention. Мoscow: Rossel’khozizdat; 1987. 64 p. Available at: https://www.booksite.ru/fulltext/1071341/text.pdf. (in Russ.)
5. Duck virus hepatitis. In: WOAH. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 2018; Chapter 3.3.8: 882–894. Available at: https://www.woah.org/fileadmin/Home/eng/Health_standards/tahm/3.03.08_DVH.pdf.
6. On approval of the list of contagious animal diseases, including highly dangerous animal diseases subjected to restrictions (quarantine): Order of the Ministry of Agriculture of Russia No. 476 of December 19, 2011. Available at: https://rsnadzor.ru/f/perechen_476.pdf. (in Russ.)
7. Veterinary regulations for the regionalization of the Russian Federation territory: approved by Order of the Ministry of Agriculture of Russia No. 635 of December 14, 2015. Available at: https://docs.cntd.ru/document/420325658. (in Russ.)
8. Adams M. J., King A. M., Carstens E. B. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2013). Arch. Virol. 2013; 158 (9): 2023–2030. DOI: 10.1007/s00705-013-1688-5.
9. Hisham I., Ellakany H. F., Selim A. A., Abdalla M. A. M., Zain El-Abideen M. A., Kilany W. H., et al. Comparative pathogenicity of duck hepatitis A virus-1 isolates in experimentally infected Pekin and Muscovy ducklings. Front. Vet. Sci. 2020; 7:234. DOI: 10.3389/fvets.2020.00234.
10. Levine P., Fabricant J. A hitherto-undescribed virus disease of ducks in North America. Cornell. Vet. 1950; 40: 71–86.
11. Liu R., Shi S., Huang Y., Chen Z., Chen C., Cheng L., et al. Comparative pathogenicity of different subtypes of duck hepatitis A virus in Pekin ducklings. Vet. Microbiol. 2019; 228: 181–187. DOI: 10.1016/j.vetmic.2018.11.030.
12. Niu Y., Ma H., Ding Y., Li Z., Sun Y., Li M., Shi Y. The pathogenicity of duck hepatitis A virus types 1 and 3 on ducklings. Poult. Sci. 2019; 98 (12): 6333–6339. DOI: 10.3382/ps/pez455.
13. Zhang R., Chen J., Zhang J., Yang Y., Li P., Lan J., et al. Novel duck hepatitis A virus type 1 isolates from adult ducks showing egg drop syndrome. Vet. Microbiol. 2018; 221: 33–37. DOI: 10.1016/j.vetmic.2018.05.023.
14. Fábricant J., Rickard C. G., Levine P. P. The pathology of duck virus hepatitis. Avian Dis. 1957; 1 (3): 256–275. DOI: 10.2307/1587740.
15. Zhang R., Yang Y., Lan J., Xie Z., Zhang X., Jiang S. Evidence of possible vertical transmission of duck hepatitis A virus type 1 in ducks. Transbound. Emerg. Dis. 2021; 68 (2): 267–275. DOI: 10.1111/tbed.13708.
16. Bezrukavaya I. Yu. Voprosy mekhanizma immuniteta pri virusnom gepatite utyat = Issues of duck virus hepatitis immunity mechanism. Nauchno-tekhnicheskii byulleten’ of the Ukrainian Poultry Research Institute. Kharkiv; 1980. (in Russ.)
17. Pan M., Yang X., Zhou L., Ge X., Guo X., Liu J., et al. Duck hepatitis A virus possesses a distinct type IV internal ribosome entry site element of picornavirus. J. Virol. 2012; 86 (2): 1129–1144. DOI: 10.1128/JVI.00306-11.
18. Zhang H., Pi J., Tang C., Yue H., Yang F. An experimental study of the pathogenicity of a duck hepatitis A virus genotype C isolate in specific pathogen free ducklings. Avian Pathol. 2012; 41 (6): 613–620. DOI: 10.1080/03079457.2012.745641.
19. Bessarabov B. F. Duck virus hepatitis. In : Infectious animal diseases. B. F. Bessarabov, A. A. Vashutin, Ye. S. Voronin et al. Edited by A. A. Sidorchuk. Мoscow: KolosS; 2007; 572–575. (in Russ.)
20. Augustinavichus V., Labutinas A. Effektivnost’ vaktsinatsii utyat i utok protiv virusnogo gepatita = Efficacy of duck virus hepatitis vaccination in ducklings and ducks. Trudy Litovskogo nauchno-issledovatel’skogo instituta veterinarii. 1970; 4: 27–33. (in Russ.)
Review
For citations:
Chesnokova A.A., Ivanova E.V., Pronin V.V., Chupina O.A., Fomenko V.Yu., Volkov M.S., Irza V.N. Results of experimental infection of vaccinated and non-vaccinated ducklings with duck hepatitis virus. Veterinary Science Today. 2022;11(4):359-366. https://doi.org/10.29326/2304-196X-2022-11-4-359-366